Cleared Special

K042252 - NEXFLEX TOTAL HIP SYSTEM (FDA 510(k) Clearance)

Class II Orthopedic device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K042252 · Alphatec/Nexmed · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2004
Decision
108d
Days
Class 2
Risk

K042252 is an FDA 510(k) clearance for the NEXFLEX TOTAL HIP SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Alphatec/Nexmed (Carlsbad, US). The FDA issued a Cleared decision on December 6, 2004 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Alphatec/Nexmed devices

Submission Details

510(k) Number K042252 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2004
Decision Date December 06, 2004
Days to Decision 108 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 122d · This submission: 108d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 558
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K042252.
G7® Revision Acetabular System
K252623 · Zimmer, Inc. · Feb 2026
Mpact 3D Metal Implants Extension – DMLS Technology
K251043 · Medacta International S.A. · Jan 2026
Velora Acetabular System
K252067 · Restor3D, Inc. · Dec 2025
TaperSet™ Hip System
K252846 · Shalby Advanced Technologies, Inc. Dba Consensus Orthopedics · Nov 2025
EMPOWR Acetabular® Liner Extension
K251833 · Encore Medical, L.P. · Nov 2025
ArTT Augments and Buttresses and Bone Screws
K251718 · Lima Corporate S.P.A. · Aug 2025